Spain· ES:06378017
INOVELON 40 mg/ml SUSPENSION ORAL
A medicinal product containing rufinamida, registered in Spain by Eisai Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- rufinamida
- Manufacturer
- Eisai Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo688710460EUR 140.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rufinamida in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBanzelEisai Inc.
- CzechiaINOVELONEisai GmbH, Frankfurt am Main
- FinlandInovelonEisai GmbH
- FranceINOVELON 40 mg/ml, suspension buvableEISAI (ROYAUME-UNI)
- IrelandInovelon 40 mg/ml oral suspensionEisai GmbH
- BelgiumInovelon 40 mg/mlEisai
- NorwayInovelonEisai GmbH
- PolandInovelonEisai GmbH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Rufinamid Actrevo, Rufinamid Micro Labs
- France · Rufinamide Actrevo, Rufinamide Medipha
- United Kingdom (Northern Ireland) · Rufinamide, Rufinamide Brown & Burk
- Iceland · Inovelon
- Liechtenstein · Inovelon
- Norway · Inovelon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8ba2be54-1ba3-4098-a927-b84f80444b35 GET /v1/drugs/8ba2be54-1ba3-4098-a927-b84f80444b35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1332198000000}",
"nregistro": "06378017",
"substance": "rufinamida"
}See everything about rufinamida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.